Cargando…

Comment on: incidence of blindness in a population of rheumatic patients treated with hydroxychloroquine: reply

Detalles Bibliográficos
Autores principales:	Singh, Dilpreet K, Muhieddine, Leila, Einstadter, Douglas, Ballou, Stanley
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6821294/ https://www.ncbi.nlm.nih.gov/pubmed/31697278 http://dx.doi.org/10.1093/rap/rkz038

Ejemplares similares

Incidence of blindness in a population of rheumatic patients treated with hydroxychloroquine
por: Singh, Dilpreet K, et al.
Publicado: (2019)

Comment on: Incidence of blindness in a population of rheumatic patients treated with hydroxychloroquine
por: Pareek, Anil, et al.
Publicado: (2019)

Reply to ‘Comment on Cancer incidence in the United Kingdom: projections to the year 2030'
por: Ahmad, A S, et al.
Publicado: (2013)

Author reply to comments
por: Bhalla, Ashu Seith, et al.
Publicado: (2015)

Hydroxychloroquine and QT Prolongation in Older Patients with Rheumatic Diseases: Who is afraid of the Boogeyman? We are not!
por: Castagna, Alberto, et al.
Publicado: (2020)

Reply to comment of Prof. Artur Czekierdowski
por: Jakiel, Grzegorz
Publicado: (2017)

Reply to the comment by Osuka et al.
por: Endo, Akira, et al.
Publicado: (2020)

Reply to “The perceived efficacy of hydroxychloroquine in observational studies: the results of the confounding effects of ‘goals of care’”
por: Dauby, Nicolas, et al.
Publicado: (2021)

Reply: Comment on alemtuzumab and inclusion body myositis
por: Dalakas, Marinos C., et al.
Publicado: (2010)

Authors' Reply to Comments from Dr. Guan
por: Inoue, Ken-ichiro, et al.
Publicado: (2009)

Redefining vitamin D deficiency: Reply to comments
por: Garg, MK, et al.
Publicado: (2014)

Reply to Comment on: Fungal keratitis: The Aravind Experience
por: Prajna, Venkatesh N, et al.
Publicado: (2018)

Authors’ Reply to Comments on ASHAs’ Perceptions on Depression
por: Mary Kapanee, Aruna Rose, et al.
Publicado: (2018)

Reply to Comment on “Osteoporosis in the Age of COVID-19”
por: Girgis, C. M., et al.
Publicado: (2021)

Reply to comment on “COVID-19 incidence and hospitalization during the delta surge were inversely related to vaccination coverage”
por: Harris, Jeffrey E.
Publicado: (2022)

Reply to ‘Comment on ‘Human papillomavirus association is the most important predictor for surgically treated patients with oropharyngeal cancer”
por: Wagner, Steffen, et al.
Publicado: (2018)

Reply to comment: Conventional manual small-incision cataract surgery
por: Yang, Jun, et al.
Publicado: (2015)

Author reply to comment on photodynamic therapy and polypoidal choroidal vasculopathy
por: Williams, Gwyn Samuel, et al.
Publicado: (2014)

Impact of hydroxychloroquine used as DMARD on SARS-CoV-2 tests and infection evolution in a population of 871 patients with inflammatory rheumatic and musculoskeletal diseases
por: Trefond, Ludovic, et al.
Publicado: (2021)

Can we use hydroxychloroquine to treat COVID-19 now?
por: Chen, Jun, et al.
Publicado: (2021)

Comment to Sands et al. — No clinical benefit in mortality associated with hydroxychloroquine treatment in patients with COVID-19
por: Hoang, Van Thuan
Publicado: (2021)

Reply to the comment of Hirota et al. on “Accuracy of flash glucose monitoring in insulin‐treated patients with type 2 diabetes”
por: Sato, Tatsuya, et al.
Publicado: (2019)

Reply to comment on: Sandwich technique using combination of perfluoropropane and silicone oil for inferior retinal detachment
por: Singh, Sumit Randhir, et al.
Publicado: (2018)

Authors’ Reply to Juergen O Kirchner’s Comment on “Incidence Rates of Autoimmune Diseases in European Healthcare Databases: A Contribution of the ADVANCE Project”
por: Willame, Corinne, et al.
Publicado: (2023)

Reply to “comment on Post-vaccination incidence and side effects of COVID-19 in a cohort of Brazilian healthcare professionals: an internet-based survey”
por: Ballestero, Matheus, et al.
Publicado: (2023)

Reply to ‘Low‐dose hydroxychloroquine therapy and lower mortality in hospitalized patients with COVID‐19: association does not mean causality’
por: Dauby, N., et al.
Publicado: (2021)

Reply to the Letter to Editor by Lacout and colleagues: Chloroquine and Hydroxychloroquine for the Treatment of COVID-19: a Systematic Review and Meta-analysis
por: Prasad, Manya, et al.
Publicado: (2021)

Reply: ‘Comments on Stromal disrupting effects of nab-paclitaxel in pancreatic cancer'
por: Alvarez, R, et al.
Publicado: (2014)

Authors’ Reply: Comment to Varied phenotype of Homocystinuria: Possible diagnostic error
por: Kaliaperumal, Subashini, et al.
Publicado: (2014)

Author reply to comment on subconjunctival limbus oblique incision for mature cataracts
por: Yang, Jun, et al.
Publicado: (2015)

Author’s reply to ‘Rickettsia retinitis cases in India: a few comments’
por: Kawali, Ankush A., et al.
Publicado: (2016)

Authors' Reply to Comments on the Association between Workplace Environment and Metabolic Syndrome
por: Soo Jeong, Hwee
Publicado: (2019)

Reply to Letter to the Editor by Griffiths et al. commenting on Evans & Allen
por: Evans, Bruce J.W., et al.
Publicado: (2017)

Reply to: comment on increased reliance on physician assistants: an access-quality tradeoff?
por: Walia, Bhavneet, et al.
Publicado: (2023)

Reply to ‘Comment on ‘Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy''
por: Fujii, Takeo, et al.
Publicado: (2017)

First evaluation of hydroxychloroquine recommendations in treating SARS-CoV-2
por: Roussel, Y., et al.
Publicado: (2020)

Author’s Reply—A double-blind case study?
por: Liu, Xiaoke, et al.
Publicado: (2021)

Reply to comments on "A reevaluation of cancer incidence near the Three Mile Island".
por: Wing, S, et al.
Publicado: (1997)

Estimated incidence of previously undetected atrial fibrillation on a 14-day continuous electrocardiographic monitor and associated risk of stroke: comment—Authors’ reply
por: McIntyre, W F, et al.
Publicado: (2022)

Possible synergistic effects of hydroxychloroquine and steroids in COVID-19, time for a nuanced approach. Comment on Arshad et al.
por: Wiseman, David M.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_crhfk6cg2e2vadtle33etgkc2l